Aspen Aerogels (NYSE:ASPN) Price Target Raised to $25.00

Aspen Aerogels (NYSE:ASPN) had its price target raised by HC Wainwright from $20.00 to $25.00 in a report issued on Friday, Benzinga reports. The firm currently has a buy rating on the construction company’s stock.

A number of other research firms have also recently commented on ASPN. Roth Mkm restated a buy rating and issued a $22.00 price target on shares of Aspen Aerogels in a report on Tuesday, April 30th. TheStreet raised shares of Aspen Aerogels from a d+ rating to a c- rating in a research report on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the company. According to MarketBeat.com, Aspen Aerogels currently has a consensus rating of Moderate Buy and a consensus target price of $25.17.

Aspen Aerogels Stock Up 5.3 %

Shares of NYSE ASPN opened at $25.11 on Friday. The company has a market cap of $1.93 billion, a P/E ratio of -57.07 and a beta of 1.97. The firm has a 50-day simple moving average of $16.72 and a two-hundred day simple moving average of $13.77. Aspen Aerogels has a 1 year low of $5.32 and a 1 year high of $25.65. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.41 and a quick ratio of 2.91.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. The company had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. Aspen Aerogels had a negative return on equity of 6.54% and a negative net margin of 10.73%. During the same quarter in the previous year, the business earned ($0.20) EPS. Research analysts anticipate that Aspen Aerogels will post 0.03 earnings per share for the current year.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Banque Cantonale Vaudoise raised its stake in Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares in the last quarter. McAdam LLC bought a new position in shares of Aspen Aerogels in the 4th quarter worth $191,000. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Aspen Aerogels by 71.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock worth $198,000 after purchasing an additional 9,601 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Aspen Aerogels by 38.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after purchasing an additional 3,607 shares in the last quarter. Finally, Cornerstone Investment Partners LLC purchased a new position in Aspen Aerogels in the fourth quarter valued at about $230,000. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.